The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
Open accessAbstract
The role of the fibronectin receptor, α5β1-integrin, as an adhesion receptor and in angiogenesis is well established. However, its role in cancer cell invasion and metastasis is less clear. We describe a novel mechanism by which fibronectin regulates ovarian cancer cell signaling and promotes metastasis. Fibronectin binding to α5β1-integrin led to a direct association of α5-integrin with the receptor tyrosine kinase, c-Met, activating it in a hepatocyte growth factor/scatter factor (HGF/SF) independent manner. Subsequently, c-Met associated with Src, and activated Src and focal adhesion kinase (FAK). Inhibition of α5β1-integrin decreased the phosphorylation of c-Met, FAK and Src, both in vitro and in vivo. Independent activation of c-Met by its native ligand, HGF/SF, or overexpression of a constitutively active FAK in HeyA8 cells could overcome the effect of α5β1-integrin inhibition on tumor cell invasion, indicating that α5β1-integrin is upstream of c-Met, Src and FAK. Inhibition of α5β1-integrin on cancer cells in two xenograft models of ovarian cancer metastasis resulted in a significant decrease of tumor burden, which was independent of the effect of α5β1-integrin on angiogenesis. These data suggest that fibronectin promotes ovarian cancer invasion and metastasis through an α5β1-integrin/c-Met/FAK/Src-dependent signaling pathway, transducing signals through c-Met in an HGF/SF-independent manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Hynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
Self-citationIntegrin-regulated FAK–Src signaling in normal and cancer cells
Mitra, S. K., & Schlaepfer, D. D. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.011 · Cited by 1,590
Integrins in angiogenesis and lymphangiogenesis
Avraamides, C. J., Garmy-Susini, B., & Varner, J. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2353 · Cited by 1,050
Embryonic mesodermal defects in α5 integrin-deficient mice
Yang, J. T., Rayburn, H., & Hynes, R. O. (1993) · Development · doi:10.1242/dev.119.4.1093 · Cited by 691
Kim, S., Bell, K., Mousa, S. A., & Varner, J. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65005-5 · Cited by 635
A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00567-0 · Cited by 420
Rab25 Associates with α5β1 Integrin to Promote Invasive Migration in 3D Microenvironments
Caswell, P. T., Spence, H. J., Parsons, M., White, D. P., Clark, K., Cheng, K. W., Mills, G. B., Humphries, M. J., Messent, A. J., Anderson, K. I., et al. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.08.012 · Cited by 387
Positional Control of Cell Fate Through Joint Integrin/Receptor Protein Kinase Signaling
Giancotti, F. G., & Tarone, G. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.031103.133334 · Cited by 374
Association of insulin receptor substrate-1 with integrins
Vuori, K., & Ruoslahti, E. (1994) · Science · doi:10.1126/science.7527156 · Cited by 360
Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target
Sawada, K., Mitra, A. K., Radjabi, A. R., Bhaskar, V., Kistner, E. O., Tretiakova, M., Jagadeeswaran, S., Montag, A., Becker, A., Kenny, H. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5167 · Cited by 356
Self-citationYu, D., Wolf, J. K., Scanlon, M., Price, J. E., & Hung, M. (1993) · PubMed · Cited by 284
Francis, S. E., Goh, K. L., Hodivala-Dilke, K., Bader, B. L., Stark, M., Davidson, D., & Hynes, R. O. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000016045.93313.f2 · Cited by 282
Sawada, K., Radjabi, A. R., Shinomiya, N., Kistner, E., Kenny, H., Becker, A. R., Turkyilmaz, M. A., Salgia, R., Yamada, S. D., Vande Woude, G. F., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1147 · Cited by 258
Self-citationIntegrin and Cadherin Synergy Regulates Contact Inhibition of Migration and Motile Activity
Huttenlocher, A., Lakonishok, M., Kinder, M., Wu, S., Truong, T., Knudsen, K. A., & Horwitz, A. F. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.2.515 · Cited by 190
MMP-2 functions as an early response protein in ovarian cancer metastasis
Kenny, H. A., & Lengyel, E. R. (2009) · Cell Cycle · doi:10.4161/cc.8.5.7703 · Cited by 155
Self-citationRicono, J. M., Huang, M., Barnes, L. A., Lau, S. K. M., Weis, S. M., Schlaepfer, D. D., Hanks, S. K., & Cheresh, D. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3612 · Cited by 145
Chen, S.-Y., & Chen, H. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02186-05 · Cited by 139
Chan, P. Y., Kanner, S. B., Whitney, G. S., & Aruffo, A. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32031-8 · Cited by 134
Oltmann‐Norden, I., Galuska, S. P., Hildebrandt, H., Geyer, R., Gerardy‐Schahn, R., Geyer, H., & Mühlenhoff, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708463200 · Cited by 123
Ren, J., Jin, P., Wang, E., Liu, E., Harlan, D. M., Li, X., & Stroncek, D. F. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-1 · Cited by 106
Nakamura, E., Kozaki, K., Tsuda, H., Suzuki, E., Pimkhaokham, A., Yamamoto, G., Irié, T., Tachikawa, T., Amagasa, T., Inazawa, J., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00838.x · Cited by 95
Taverna, D., & Hynes, R. O. (2001) · PubMed · Cited by 94
Bhaskar, V., Zhang, D., Fox, M., Seto, P., Wong, M. H. L., Wales, P., Powers, D., Chao, D. T., DuBridge, R. B., & Ramakrishnan, V. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-61 · Cited by 87
Uniform Overexpression and Rapid Accessibility of α5β1 Integrin on Blood Vessels in Tumors
Parsons‐Wingerter, P. A., Kasman, I. M., Norberg, S. M., Magnussen, A., Zanivan, S. R., Rissone, A., Bałuk, P., Favre, C., Jeffry, U. B., Murray, R., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62965-3 · Cited by 85
Zillhardt, M., Christensen, J. G., & Lengyel, E. R. (2010) · Neoplasia · doi:10.1593/neo.09948 · Cited by 76
Self-citationRadjabi, A. R., Sawada, K., Jagadeeswaran, S., Eichbichler, A. J. M., Kenny, H. A., MONTAG, A. G., Bruno, K., & Lengyel, E. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704855200 · Cited by 76
Self-citationMagnussen, A., Kasman, I. M., Norberg, S. M., Bałuk, P., Murray, R., & McDonald, D. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2691 · Cited by 67
Jin, E., Choi, Y., Park, E. K., Bang, O., & Kang, S. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.06.003 · Cited by 54
Nakamura, Y., Matsubara, D., Goto, A., Ota, S., Oguni, S., Ishikawa, S., Aburatani, H., Miyazawa, K., Fukayama, M., & Niki, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00640.x · Cited by 53
Saga, Y., Mizukami, H., Suzuki, M., Urabe, M., Kume, A., Nakamura, T., Sato, I., & Ozawa, K. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301553 · Cited by 48
Wong, A. S. T., Roskelley, C. D., Pelech, S., Miller, D. M., Leung, P. C. K., & Auersperg, N. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.06.002 · Cited by 45
Crosstalk between hepatocyte growth factor and integrin signaling pathways
Chan, P.-C., Chen, S.-Y., Chen, C.-H., & Chen, H. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-005-9061-7 · Cited by 40
Association between fibronectin expression and prognosis in ovarian carcinoma.
Franke, F. E., von Georgi, R., Zygmunt, M., & Münstedt, K. (2003) · PubMed · Cited by 39
Endostatin Binding to Ovarian Cancer Cells Inhibits Peritoneal Attachment and Dissemination
Yokoyama, Y., Sedgewick, G. J., & Ramakrishnan, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0172 · Cited by 32
Hafter, R. E., Klaubert, W., Gollwitzer, R., von Hugo, R., & Graeff, H. (1984) · Thrombosis Research · doi:10.1016/0049-3848(84)90312-8 · Cited by 31
Cited by
Every step of the way: integrins in cancer progression and metastasis
Hamidi, H., & Ivaska, J. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0038-z · Cited by 1,493
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Cirri, P., & Chiarugi, P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9340-x · Cited by 519
Activation of fibroblasts in cancer stroma
Räsänen, K., & Vaheri, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.032 · Cited by 499
Extracellular matrix, integrins, and growth factors as tailors of the stem cell niche
Brizzi, M. F., Tarone, G., & Defilippi, P. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.07.001 · Cited by 412
Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium
Iwanicki, M. P., Davidowitz, R. A., Ng, M. R., Besser, A., Muranen, T., Merritt, M., Danuser, G., Ince, T., & Brugge, J. S. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-11-0010 · Cited by 303
Metadata
- Authors
- Mitra, A. K., Sawada, K., Tiwari, P., Mui, K., Gwin, K., & Lengyel, E.
- Venue
- Oncogene
- Published
- 2010-11-29
- Volume
- 30
- Issue
- 13
- Pages
- 1566-1576
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2025880272
- Cited by
- 274
- References
- 38
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.